TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 94 filers reported holding TERNS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,792,958 | -67.1% | 555,260 | -42.8% | 1.87% | -67.4% |
| Q2 2023 | $8,487,500 | -34.8% | 970,000 | -11.8% | 5.75% | -40.0% |
| Q1 2023 | $13,015,819 | +16.2% | 1,099,309 | -0.1% | 9.59% | +39.2% |
| Q4 2022 | $11,198,000 | +442.0% | 1,100,000 | +213.7% | 6.89% | +674.3% |
| Q3 2022 | $2,066,000 | – | 350,702 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,099,309 | $13,015,819 | 9.59% |
| VR Adviser, LLC | 3,619,522 | $42,855,140 | 8.37% |
| Vivo Capital, LLC | 6,657,992 | $78,830,625 | 5.47% |
| Fairmount Funds Management LLC | 2,040,000 | $24,153,600 | 4.15% |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $8,457,134 | 3.41% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 667,922 | $7,908,196 | 3.26% |
| Ikarian Capital, LLC | 721,341 | $8,540,677 | 1.94% |
| Orbimed Advisors | 7,619,135 | $90,210,558 | 1.77% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,448,275 | $40,827,576 | 1.72% |
| CROSSPOINT FINANCIAL, LLC | 12,054 | $142,719 | 1.54% |